epigallocatechin gallate has been researched along with cyc 202 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bui, LC; Cariou, K; Dairou, J; Delabar, JM; Denhez, C; Dodd, RH; Gourdain, S; Janel, N; Rodrigues-Lima, F | 1 |
| Jarhad, DB; Jeong, LS; Kim, HR; Mashelkar, KK; Noh, M | 1 |
1 review(s) available for epigallocatechin gallate and cyc 202
| Article | Year |
|---|---|
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
Topics: Animals; Biological Products; Disease; Dyrk Kinases; Enzyme Activation; Humans; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases | 2018 |
1 other study(ies) available for epigallocatechin gallate and cyc 202
| Article | Year |
|---|---|
Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity.
Topics: Dyrk Kinases; Enzyme Inhibitors; Humans; Hydrogen Bonding; Indoles; KB Cells; Molecular Docking Simulation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyridines | 2013 |